CBAY Stock Price | CymaBay Therapeutics Inc. Stock Quote (U.S.: Nasdaq)

0
25


CymaBay Therapeutics Inc.

CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA.



Source : MTV